Tesamorelin + Ipamorelin – Dual Secretagogue Peptide Blend (10mg / 3mg)
Overview
Tesamorelin + Ipamorelin is a dual-peptide formulation designed exclusively for advanced laboratory studies investigating growth hormone (GH) signaling mechanisms. Combining Tesamorelin (GHRH analog) and Ipamorelin (ghrelin receptor agonist), this blend enables researchers to model dual-pathway secretagogue activity with precision and temporal flexibility.
The compound is supplied as a sterile, lyophilized powder, validated at ≥99% purity, and formulated for reconstitution in controlled in vitro environments.
Product Specifications
| Attribute | Description |
|---|---|
| Peptides Included | Tesamorelin 10 mg + Ipamorelin 3 mg |
| Form | Lyophilized peptide powder |
| Purity | ≥99% (HPLC-verified) |
| Solubility | Sterile bacteriostatic water |
| Storage (Unopened) | –20°C; dry, light-protected |
| Storage (After Mixing) | 2–8°C; use within 30 days |
| Intended Use | Research use only |
Research Applications
This combination supports a wide range of investigational protocols, including:
- Dual-Receptor GH Signaling Models: In vitro GH release studies targeting GHRH and GHSR pathways simultaneously.
- Endocrine Axis Simulations: GH–IGF pathway mapping, receptor feedback loops, and crosstalk analysis.
- Tissue Signaling Research: Evaluation of muscle cell models, matrix protein regulation, and regenerative markers.
- Somatotropic Aging Models: Studies focused on GH decline in aging and metabolic adaptation under experimental conditions.
All applications are restricted to controlled, non-clinical laboratory settings.
Scientific Advantages
- Dual Mechanism Design
- Tesamorelin activates GHRH receptors
- Ipamorelin selectively targets ghrelin receptors with minimal off-target effects (e.g., ACTH or prolactin pathways)
- Temporal Flexibility
- Ipamorelin: Rapid onset, shorter in vitro half-life
- Tesamorelin: Prolonged GHRH mimetic effect
- Signal Precision: Engineered for receptor-specific studies without undesired hormonal interference common in broader-spectrum secretagogues.
Reconstitution & Handling Instructions
- Use aseptic technique for reconstitution with sterile bacteriostatic water
- Swirl gently—do not shake to avoid peptide breakdown
- Store reconstituted solution refrigerated at 2–8°C
- Do not freeze after mixing
- Discard after 30 days or per your laboratory’s protocol
Disclaimer
This product is intended strictly for qualified laboratory research. It is not a therapeutic agent, dietary supplement, or clinical material. No claims are made or implied regarding health benefits, safety, or effectiveness in any setting outside of controlled, in vitro research.
There are no reviews yet.